Published in Am J Ophthalmol on February 01, 2005
Comparison of Autologous Serum Versus Preservative Free Artificial Tear | NCT02752763
Umbilical Cord Serum Versus Conventional Eyedrops | NCT04217785
[Current treatment for dry eye syndrome]. Ophthalmologe (2006) 1.53
Tear dysfunction and the cornea: LXVIII Edward Jackson Memorial Lecture. Am J Ophthalmol (2011) 1.18
National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease: V. The 2014 Ancillary Therapy and Supportive Care Working Group Report. Biol Blood Marrow Transplant (2015) 0.98
Efficacy of a 2-month dietary supplementation with polyunsaturated fatty acids in dry eye induced by scopolamine in a rat model. Graefes Arch Clin Exp Ophthalmol (2009) 0.96
Diagnostic procedures and management of dry eye. Biomed Res Int (2013) 0.91
Managing Sjögren's Syndrome and non-Sjögren Syndrome dry eye with anti-inflammatory therapy. Clin Ophthalmol (2014) 0.89
Autologous serum eye drops for dry eye. Cochrane Database Syst Rev (2013) 0.88
The role and treatment of inflammation in dry eye disease. Int Ophthalmol (2014) 0.84
The efficacy of autologous serum eye drops for severe dry eye syndrome: a randomized double-blind crossover study. Graefes Arch Clin Exp Ophthalmol (2014) 0.83
Topical 100% serum eye drops for treating corneal epithelial defect after ocular surgery. Biomed Res Int (2013) 0.82
Evaluation of the efficacy of 50% autologous serum eye drops in different ocular surface pathologies. Biomed Res Int (2014) 0.80
Targeting growth factor supply in keratopathy treatment: comparison between maternal peripheral blood and cord blood as sources for the preparation of topical eye drops. Blood Transfus (2015) 0.80
Bioengineered Lacrimal Gland Organ Regeneration in Vivo. J Funct Biomater (2015) 0.80
Therapeutic Strategies to Treat Dry Eye in an Aging Population. Drugs Aging (2015) 0.79
[Manufacture of autologous serum eye drops for out-patient therapy : cooperation between ophthalmic clinic and transfusion medicine department]. Ophthalmologe (2008) 0.78
The effect of autologous serum eye drops in the treatment of severe dry eye disease: a prospective randomized case-control study. Am J Ophthalmol (2005) 0.77
Autologous Platelet-rich Plasma Eye Drops in the Treatment of Recurrent Corneal Erosions. Korean J Ophthalmol (2016) 0.77
Treating Sjögren's Syndrome: Insights for the Clinician. Ther Adv Musculoskelet Dis (2010) 0.77
A Case-Control Study on the Oxidative Balance of 50% Autologous Serum Eye Drops. Oxid Med Cell Longev (2016) 0.77
Expert opinion in the management of aqueous Deficient Dry Eye Disease (DED). BMC Ophthalmol (2015) 0.77
Treating ocular surface disease: new agents in development. Clin Ophthalmol (2011) 0.77
[Ophthalmological complications in Sjögren's syndrome]. Z Rheumatol (2010) 0.76
Outcomes of different concentrations of human amniotic fluid in a keratoconjunctivitis sicca-induced mouse model. Int Ophthalmol (2016) 0.76
Use of umbilical cord serum in ophthalmology. Chonnam Med J (2014) 0.76
Graft failure: II. Ocular surface complications. Int Ophthalmol (2008) 0.76
Identification of transcription factors that promote the differentiation of human pluripotent stem cells into lacrimal gland epithelium-like cells. NPJ Aging Mech Dis (2017) 0.76
The use of autologous serum for the treatment of ocular surface disease at a Swedish tertiary referral center. Int Med Case Rep J (2016) 0.75
Long-term rebamipide and diquafosol in two cases of immune-mediated dry eye. Optom Vis Sci (2015) 0.75
Human Serum Eye Drops in Eye Alterations: An Insight and a Critical Analysis. J Ophthalmol (2015) 0.75
The Effect of Autologous Platelet Lysate Eye Drops: An In Vivo Confocal Microscopy Study. Biomed Res Int (2016) 0.75
Autologous serum eye drops for dry eye. Cochrane Database Syst Rev (2017) 0.75
Dry Eye Management: Targeting the Ocular Surface Microenvironment. Int J Mol Sci (2017) 0.75
A novel clinical entity, IgG4-related disease (IgG4RD): general concept and details. Mod Rheumatol (2011) 4.26
Modified double-K method for intraocular lens power calculation after excimer laser corneal refractive surgery. J Cataract Refract Surg (2013) 3.29
The international workshop on meibomian gland dysfunction: report of the subcommittee on management and treatment of meibomian gland dysfunction. Invest Ophthalmol Vis Sci (2011) 2.66
Drusen, choroidal neovascularization, and retinal pigment epithelium dysfunction in SOD1-deficient mice: a model of age-related macular degeneration. Proc Natl Acad Sci U S A (2006) 2.40
The international workshop on meibomian gland dysfunction: executive summary. Invest Ophthalmol Vis Sci (2011) 2.28
No forward shifting of posterior corneal surface in eyes undergoing LASIK. Ophthalmology (2007) 2.21
Topography-guided conductive keratoplasty: treatment for advanced keratoconus. Am J Ophthalmol (2010) 2.10
Ocular surface changes with applanation contact lens and coupling fluid use after argon laser photocoagulation in noninsulin-dependent diabetes mellitus. Am J Ophthalmol (2004) 2.06
Impaired functional visual acuity of dry eye patients. Am J Ophthalmol (2002) 1.94
Long-term outcome of keratolimbal allograft with or without penetrating keratoplasty for total limbal stem cell deficiency. Ophthalmology (2002) 1.81
The international workshop on meibomian gland dysfunction: report of the diagnosis subcommittee. Invest Ophthalmol Vis Sci (2011) 1.80
The effect of periocular warming on accommodation. Ophthalmology (2005) 1.74
New grading system for the evaluation of chronic ocular manifestations in patients with Stevens-Johnson syndrome. Ophthalmology (2007) 1.71
Oxidative stress induced inflammation initiates functional decline of tear production. PLoS One (2012) 1.64
Prevalence of dry eye disease among Japanese visual display terminal users. Ophthalmology (2008) 1.61
Suppression of diabetes-induced retinal inflammation by blocking the angiotensin II type 1 receptor or its downstream nuclear factor-kappaB pathway. Invest Ophthalmol Vis Sci (2007) 1.59
Hypoxia disrupts the barrier function of neural blood vessels through changes in the expression of claudin-5 in endothelial cells. Am J Pathol (2007) 1.54
Mathematical projection model of visual loss due to fuchs corneal dystrophy. Invest Ophthalmol Vis Sci (2011) 1.53
Cytokeratin 15 can be used to identify the limbal phenotype in normal and diseased ocular surfaces. Invest Ophthalmol Vis Sci (2006) 1.53
Noninvasive interference tear meniscometry in dry eye patients with Sjögren syndrome. Am J Ophthalmol (2007) 1.51
Isolation of multipotent neural crest-derived stem cells from the adult mouse cornea. Stem Cells (2006) 1.49
Autologous serum application in the treatment of neurotrophic keratopathy. Ophthalmology (2004) 1.48
Biological effects of blocking blue and other visible light on the mouse retina. Clin Experiment Ophthalmol (2013) 1.46
Quantitative evaluation of night vision and correlation of refractive and topographical parameters with glare after orthokeratology. Graefes Arch Clin Exp Ophthalmol (2011) 1.46
Subjective visual sensation during vitrectomy under retrobulbar anesthesia. Am J Ophthalmol (2006) 1.46
The comparison of solitary topical micafungin or fluconazole application in the treatment of Candida fungal keratitis. Br J Ophthalmol (2010) 1.43
Prevalence and risk factors of dry eye disease in Japan: Koumi study. Ophthalmology (2011) 1.43
The features of dry eye disease in a Japanese elderly population. Optom Vis Sci (2006) 1.41
Ocular integrity after anterior ciliary sclerotomy and scleral ablation by the Er:YAG laser. J Refract Surg (2005) 1.41
Tear function and ocular surface findings in premature and term babies. Ophthalmology (2004) 1.41
Effect of age on changes in anterior chamber depth and volume after laser in situ keratomileusis. J Cataract Refract Surg (2009) 1.41
Revised Japanese criteria for Sjögren's syndrome (1999): availability and validity. Mod Rheumatol (2004) 1.40
Clinical evaluation of the arched blade for cataract surgery. Acta Ophthalmol Scand (2005) 1.40
Microkeratome-assisted phacoemulsification. J Cataract Refract Surg (2005) 1.38
Prevalence of dry eye disease and its risk factors in visual display terminal users: the Osaka study. Am J Ophthalmol (2013) 1.37
Laboratory findings in tear fluid analysis. Clin Chim Acta (2006) 1.36
Transplantation of human limbal epithelium cultivated on amniotic membrane for the treatment of severe ocular surface disorders. Ophthalmology (2002) 1.35
Beta-catenin activation and epithelial-mesenchymal transition in the pathogenesis of pterygium. Invest Ophthalmol Vis Sci (2007) 1.30
Randomized clinical trial of deep lamellar keratoplasty vs penetrating keratoplasty. Am J Ophthalmol (2002) 1.30
A randomised, double-masked comparison study of diquafosol versus sodium hyaluronate ophthalmic solutions in dry eye patients. Br J Ophthalmol (2012) 1.29
The challenge of dry eye diagnosis. Clin Ophthalmol (2008) 1.28
In vivo confocal microscopy of the ocular surface: from bench to bedside. Curr Eye Res (2013) 1.27
Prevention of ocular inflammation in endotoxin-induced uveitis with resveratrol by inhibiting oxidative damage and nuclear factor-kappaB activation. Invest Ophthalmol Vis Sci (2009) 1.25
Deep anterior lamellar keratoplasty. Curr Opin Ophthalmol (2006) 1.25
Neuroprotective effects of angiotensin II type 1 receptor (AT1R) blocker, telmisartan, via modulating AT1R and AT2R signaling in retinal inflammation. Invest Ophthalmol Vis Sci (2006) 1.24
Involvement of oxidative stress on corneal epithelial alterations in a blink-suppressed dry eye. Invest Ophthalmol Vis Sci (2007) 1.24
(Pro)renin receptor-mediated signal transduction and tissue renin-angiotensin system contribute to diabetes-induced retinal inflammation. Diabetes (2009) 1.24
Interleukin-6 receptor-mediated activation of signal transducer and activator of transcription-3 (STAT3) promotes choroidal neovascularization. Am J Pathol (2007) 1.23
The application of a new continuous functional visual acuity measurement system in dry eye syndromes. Am J Ophthalmol (2005) 1.21
Neuroprotective effect of an antioxidant, lutein, during retinal inflammation. Invest Ophthalmol Vis Sci (2008) 1.21
Serum-free spheroid culture of mouse corneal keratocytes. Invest Ophthalmol Vis Sci (2005) 1.20
Intrinsic signal imaging in macaque retina reveals different types of flash-induced light reflectance changes of different origins. Invest Ophthalmol Vis Sci (2007) 1.20
Angiotensin II type 1 receptor signaling contributes to synaptophysin degradation and neuronal dysfunction in the diabetic retina. Diabetes (2008) 1.19
Suppression of ocular inflammation in endotoxin-induced uveitis by blocking the angiotensin II type 1 receptor. Invest Ophthalmol Vis Sci (2005) 1.18
The application of in vivo laser confocal microscopy to the diagnosis and evaluation of meibomian gland dysfunction. Mol Vis (2008) 1.18
Tearful relations: oxidative stress, inflammation and eye diseases. Arq Bras Oftalmol (2009) 1.18
Dietary restriction: standing up for sirtuins. Science (2010) 1.17
Eicosapentaenoic acid is anti-inflammatory in preventing choroidal neovascularization in mice. Invest Ophthalmol Vis Sci (2007) 1.17
Macular pigment lutein is antiinflammatory in preventing choroidal neovascularization. Arterioscler Thromb Vasc Biol (2007) 1.16
A new mouse model of dry eye disease: oxidative stress affects functional decline in the lacrimal gland. Cornea (2012) 1.14
Tear evaporation dynamics in normal subjects and subjects with obstructive meibomian gland dysfunction. Invest Ophthalmol Vis Sci (2003) 1.14
Suppression of ocular inflammation in endotoxin-induced uveitis by inhibiting nonproteolytic activation of prorenin. Invest Ophthalmol Vis Sci (2006) 1.14
The transcriptional repressor RP58 is crucial for cell-division patterning and neuronal survival in the developing cortex. Dev Biol (2009) 1.13
Transcorneal electrical stimulation of retina to treat longstanding retinal artery occlusion. Graefes Arch Clin Exp Ophthalmol (2007) 1.13
Functional corneal endothelium derived from corneal stroma stem cells of neural crest origin by retinoic acid and Wnt/β-catenin signaling. Stem Cells Dev (2012) 1.12
Autologous serum eye drops for the treatment of dry eye diseases. Cornea (2008) 1.12